Pay in 4 interest-free payments of $6.95 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Safety and efficacy of tirzepatide as an add-on to single oral antihyperglycaemic medication in patients with type 2 diabetes in Japan (SURPASS J-combo): a multicentre, randomised, open-label, parallel-group, phase 3 trial
It amplifies pathways your body already uses to heal
The team discusses how Katie excels at developing scientifically valid research that delivers actionable insights for brands without requiring pharmaceutical-scale budgets
Kiesewetter DO, Gao H, Ma Y, Niu G, Quan Q, Guo N, Chen X
These personalized adjustments, made in consultation with healthcare providers, can significantly improve treatment tolerability and long-term adherence
US$ 24.56
US$ 28.15
US$ 22.89
US$ 26.42
